Andrea D Shields

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi request reprint Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model
    Andrea D Shields
    Department OB GYN, Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA
    Am J Obstet Gynecol 193:1144-8. 2005
  2. ncbi request reprint Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells
    Jennifer L Gotkin
    Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA
    Am J Obstet Gynecol 195:1015-9. 2006
  3. ncbi request reprint 17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619
    Damian J Paonessa
    Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431 1100, USA
    Am J Obstet Gynecol 195:1011-4. 2006

Detail Information

Publications3

  1. ncbi request reprint Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model
    Andrea D Shields
    Department OB GYN, Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA
    Am J Obstet Gynecol 193:1144-8. 2005
    ..The purpose of this study was to determine if progesterone has an effect on fetoplacental artery production of inflammatory cytokines...
  2. ncbi request reprint Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells
    Jennifer L Gotkin
    Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA
    Am J Obstet Gynecol 195:1015-9. 2006
    ..The purpose of this study was to characterize effect of progesterone (P4) on interleukin-6 (IL-6) production by fetoplacental artery explants, fetal granulocytes, and fetal and maternal mononuclear cells...
  3. ncbi request reprint 17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619
    Damian J Paonessa
    Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431 1100, USA
    Am J Obstet Gynecol 195:1011-4. 2006
    ..This study was undertaken to determine whether 17-hydroxyprogesterone caproate (17P) has a vasoactive effect on fetoplacental vasculature...